Delivery Order SPE2DB22D1106-SPE2DB25FDNB3

Award Date 11/26/24
Potential Completion Date 11/27/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,822.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Sumatriptan 6 mg/0.5 ml autoinjectors, a medication used to treat migraine headaches. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a $1,005.11 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Sumatriptan 6 mg/0.5 ml autoinjectors. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,044.80 firm fixed-price delivery order contract covers the supply of Sumatriptan 6 mg/0.5 ml autoinjectors, a prescription medication used to treat migraine headaches. The contract has an ultimate completion date of January 13, 2025 and does not have a set-aside designation, indicating open competition....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sumatriptan 6 mg/0.5 ml autoinjectors, a medication used to treat migraines. The delivery order has a ceiling value of $6,064.16 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sumatriptan 6 mg/0.5 ml autoinjectors, a prescription medication used to treat migraines. The contract is a firm-fixed-price delivery order with a ceiling value of $3,775.79 and an ultimate completion date of April 4, 2025. The contract was awarded on April 3, 2025 and does not have a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sumatriptan 6 mg/0.5 mL autoinjector medical supplies. The $1,535.58 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award, valued at $8,543.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,156,038 units of the medication Sumatriptan 6 mg/0.5 ml Autoinjector. This is a firm-fixed-price delivery order contract with a performance period ending on May 7, 2025. The contract was not set aside for any specific business type. As a large pharmaceutical supplier, AmerisourceBergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sumatriptan 6 mg/0.5 ml autoinjectors, a medication used to treat migraines. The contract has a ceiling value of $15,921.08 and is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,989.07, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566121544 - Sumatriptan 6 mg/0.5ml autoinjector, a migraine medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through October 17, 2024. The award was made on October 16, 2024, and there was no...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,407,947 units of Sumatriptan 6 mg/0.5 mL autoinjectors, a medication used to treat migraine headaches. The contract has a ceiling value of $3,883.20 and an ultimate completion date of November 13, 2024. The contract is not designated with a set-aside...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDNB3
    Delivery Order

This federal contract award, valued at $2,573.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566552159 - Sumatriptan 6 mg/0.5 ml auto-injectors, a medication used to treat migraines. The contract is a Firm Fixed Price Delivery Order with a completion date of November 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/25/25, 10:22 AM